MiNK Therapeutics, Inc. (INKT) Free cash flow 2021–2024
MiNK Therapeutics, Inc. (INKT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.6MFY2024 · since FY2021: -$12.9M → -$9.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$9.6M | +39.9% |
| FY2023 | -$16.0M | +16.2% |
| FY2022 | -$19.1M | -47.9% |
| FY2021 | -$12.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More INKT financial trends
INKT RevenueINKT Net incomeINKT Net marginINKT Gross profitINKT Gross marginINKT Operating incomeINKT Operating marginINKT Operating cash flowINKT Capital expendituresINKT Return on equityINKT Stock buybacksINKT Dividends paidINKT Total assetsINKT Total liabilitiesINKT Shareholders’ equityINKT overview →